182 related articles for article (PubMed ID: 29570919)
1. De novo CMV-associated collapsing focal segmental glomerulosclerosis in a kidney transplant recipient.
Patel AM; Zenenberg RD; Goldberg RJ
Transpl Infect Dis; 2018 Jun; 20(3):e12884. PubMed ID: 29570919
[TBL] [Abstract][Full Text] [Related]
2. [Collapsing focal segmental glomerulosclerosis induced by cytomegalovirus: A case report].
Grèze C; Garrouste C; Kemeny JL; Philipponnet C; Aniort J; Heng AÉ
Nephrol Ther; 2018 Feb; 14(1):50-53. PubMed ID: 29191574
[TBL] [Abstract][Full Text] [Related]
3. CMV-associated collapsing focal segmental glomerulosclerosis after kidney transplant in a pediatric patient.
Parr MFE; Hidalgo G; Goldstein MJ; Batal I; Lieberman KV; Amoruso MR; Baer AZ; Jain NG
Pediatr Transplant; 2023 Aug; 27(5):e14535. PubMed ID: 37128132
[TBL] [Abstract][Full Text] [Related]
4. Focal segmental glomerulosclerosis associated with acute cytomegalovirus infection in a renal transplant.
Wynd E; Stewart A; Burke J
Pediatr Transplant; 2019 Sep; 23(6):e13538. PubMed ID: 31271240
[TBL] [Abstract][Full Text] [Related]
5. Recurrent and persistent cytomegalovirus infection in a kidney recipient caused by the L595S mutation in UL97 phosphotransferase gene.
Peixoto M; Mascarenhas L; Cunha A; Dutra M; Miranda E; Silva I; Costa S; Galvão B; Cunha A
Antivir Ther; 2012; 17(3):585-8. PubMed ID: 22293247
[TBL] [Abstract][Full Text] [Related]
6. Focal segmental glomerulosclerosis after renal transplantation.
Shimizu A; Higo S; Fujita E; Mii A; Kaneko T
Clin Transplant; 2011 Jul; 25 Suppl 23():6-14. PubMed ID: 21623907
[TBL] [Abstract][Full Text] [Related]
7. A deletion at CMV UL54 codon 524 without co-existing resistance-associated mutation at UL97 confers resistance to ganciclovir: A case report.
Green CB; O'Riordan A; Griffiths P; Haque T
J Clin Virol; 2016 Jul; 80():24-6. PubMed ID: 27131599
[TBL] [Abstract][Full Text] [Related]
8. Incidence and outcomes of ganciclovir-resistant cytomegalovirus infections in 1244 kidney transplant recipients.
Myhre HA; Haug Dorenberg D; Kristiansen KI; Rollag H; Leivestad T; Asberg A; Hartmann A
Transplantation; 2011 Jul; 92(2):217-23. PubMed ID: 21685829
[TBL] [Abstract][Full Text] [Related]
9. A new mutation in the human cytomegalovirus UL97 gene may confer ganciclovir resistance in Chinese kidney transplant recipients.
Zhang Y; Zhao Z; Sun J; Cao G; Zhao F; Hu J; Liu L; Ji Y
Arch Virol; 2013 Jan; 158(1):247-50. PubMed ID: 23011309
[TBL] [Abstract][Full Text] [Related]
10. Use of high-dose ganciclovir for a resistant cytomegalovirus infection due to UL97 mutation.
West P; Schmiedeskamp M; Neeley H; Oberholzer J; Benedetti E; Kaplan B
Transpl Infect Dis; 2008 Apr; 10(2):129-32. PubMed ID: 17605740
[TBL] [Abstract][Full Text] [Related]
11. [Disease by CMV resistant to Ganciclovir. Should plasma valganciclovir levels be monitored in high risk patients?].
Sola E; Vega E; Gutiérrez C; López V; Cabello M; Burgos D; González Molina M; Siles J
Nefrologia; 2009; 29(2):180-1. PubMed ID: 19396331
[No Abstract] [Full Text] [Related]
12. Cytomegalovirus UL97 mutations associated with ganciclovir resistance in immunocompromised patients from Argentina.
Sánchez Puch S; Ochoa C; Carballal G; Zala C; Cahn P; Brunet R; Salomón H; Videla C
J Clin Virol; 2004 Jul; 30(3):271-5. PubMed ID: 15135748
[TBL] [Abstract][Full Text] [Related]
13. Early selection of a new UL97 mutant with a severe defect of ganciclovir phosphorylation after valaciclovir prophylaxis and short-term ganciclovir therapy in a renal transplant recipient.
Hantz S; Michel D; Fillet AM; Guigonis V; Champier G; Mazeron MC; Bensman A; Denis F; Mertens T; Dehee A; Alain S
Antimicrob Agents Chemother; 2005 Apr; 49(4):1580-3. PubMed ID: 15793144
[TBL] [Abstract][Full Text] [Related]
14. Collapsing glomerulopathy in a renal transplant recipient: potential molecular mechanisms.
Dogan E; Ghanta M; Tanriover B
Ann Transplant; 2011; 16(2):113-6. PubMed ID: 21716195
[TBL] [Abstract][Full Text] [Related]
15. The emergence of cytomegalovirus resistance to ganciclovir therapy in kidney transplant recipients.
Nogueira E; Ozaki KS; Tomiyama H; Granato CF; Camara NO; Pacheco-Silva A
Int Immunopharmacol; 2006 Dec; 6(13-14):2031-7. PubMed ID: 17161359
[TBL] [Abstract][Full Text] [Related]
16. Donor's APOL1 Risk Genotype and "Second Hits" Associated With De Novo Collapsing Glomerulopathy in Deceased Donor Kidney Transplant Recipients: A Report of 5 Cases.
Chang JH; Husain SA; Santoriello D; Stokes MB; Miles CD; Foster KW; Li Y; Dale LA; Crew RJ; Cohen DJ; Kiryluk K; Gharavi AG; Mohan S
Am J Kidney Dis; 2019 Jan; 73(1):134-139. PubMed ID: 30054024
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment with foscarnet for ganciclovir-resistant cytomegalovirus infection in a kidney transplant recipient: A case report.
Iwami D; Ogawa Y; Fujita H; Morita K; Sasaki H; Oishi Y; Higuchi H; Hatanaka K; Shinohara N
Nephrology (Carlton); 2016 Jul; 21 Suppl 1():63-6. PubMed ID: 26970406
[TBL] [Abstract][Full Text] [Related]
18. Cytomegalovirus ischemic colitis and transverse myelitis in a renal transplant recipient.
Gorsane I; Aloui S; Letaif A; Hadhri R; Haouala F; Frih A; Dhia NB; Elmay M; Skhiri H
Saudi J Kidney Dis Transpl; 2013 Mar; 24(2):309-14. PubMed ID: 23538355
[TBL] [Abstract][Full Text] [Related]
19. Panresistant cytomegalovirus in a kidney transplant recipient.
Yost SE; Echeverria A; Jie T; Kaplan B
Pharmacotherapy; 2014 Jan; 34(1):e1-3. PubMed ID: 24277702
[TBL] [Abstract][Full Text] [Related]
20. Cytomegalovirus resistance in solid organ transplant recipients treated with intravenous ganciclovir or oral valganciclovir.
Boivin G; Goyette N; Rollag H; Jardine AG; Pescovitz MD; Asberg A; Ives J; Hartmann A; Humar A
Antivir Ther; 2009; 14(5):697-704. PubMed ID: 19704173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
